[Exploration of conditions for releasing microvesicle from human bone marrow mesenchymal stem cells].
The release of microvesicles(MV) is one of the critical mechanisms underlying the angiogenesis-promoting activity of mesenchymal stem cells(MSC). This study was aimed to explore the appropriate condition under which MSC releases MV. Bone marrow samples from 5 healthy adults were collected, and MSC were isolated, culture-expanded and identified. MSC at passage 5 were suspended in medium without or medium with 10% fetal(FCS) calf serum and seeded into culture dishes. The culture was separately maintained in hypoxia (1% oxygen) or normoxia (around 20% oxygen), and 20 dishes of cells (2×10(6)/dish) were used for each group. The supernatants were collected for MV harvesting. The cell number was counted with trypan blue exclusion test and the protein contents in the MV were determined. MV were identified by observation under an electron microscope. The surface markers on MV were analyzed by flow cytometry. MTT test was performed to observe the pro-proliferative activity of MV that were added into the culture of human umbilical cord vein endothelial cells at a concentration of 10 µg/ml. The results showed that the majority of MV released by MSC were with diameters of less than 100 nm, and MV took the featured membrane-like structure with a hypodense center. They expressed CD29, CD44, CD73 and CD105, while they were negative for CD31 and CD45. The increase multiples of the adherent trypan blue-resistant cells cultured in normoxia with serum, in normoxia without serum, in hypoxia with serum and hypoxia in the absence of serum were 4.05 ± 0.73, 1.77 ± 0.48, 5.80 ± 0.65 and 3.69 ± 0.85 respectively, and the estimated protein contents per 10(8) cells were 463.48 ± 138.74 µg, 1604.07 ± 445.28 µg, 2389.64 ± 476.75 µg and 3141.18 ± 353.01 µg. MTT test showed that MV collected from MSC in hypoxia seemed to promote the growth of endothelial cells more efficiently than those from cells in normoxia. It is concluded that hypoxia can enhance the release of microvesicles from MSC, and cultivation of MSC in hypoxia and medium without serum may provide an appropriate condition for MV harvesting.
Nan-Fang Center of Biological Diagnosis and Therapy, Hospital of Developmental District of Guangzhou, Guangzhou 510730, Guangdong Province, China.
Xiao-Yun
XY
Bi
Nan-Fang Center of Biological Diagnosis and Therapy, Hospital of Developmental District of Guangzhou, Guangzhou 510730, Guangdong Province, China.
Shu
S
Huang
Nan-Fang Center of Biological Diagnosis and Therapy, Hospital of Developmental District of Guangzhou, Guangzhou 510730, Guangdong Province, China.
Jing-Li
JL
Chen
Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Fang
F
Wang
Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Yan
Y
Wang
Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, China. E-mail: guozk@bmi.ac.cn.
Zi-Kuan
ZK
Guo
D001854:Bone Marrow Cells / Q000166:cytology / Q000378:metabolism*; D021941:Caveolae / Q000378:metabolism*; D055252:Cell-Derived Microparticles / Q000378:metabolism*; D002478:Cells, Cultured; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000378:metabolism*